S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
NASDAQ:ZIVO

ZIVO Bioscience (ZIVO) Stock Price, News & Analysis

$6.90
+0.09 (+1.32%)
(As of 04/17/2024 ET)
Today's Range
$6.90
$8.00
50-Day Range
$6.81
$9.50
52-Week Range
$0.48
$19.08
Volume
782 shs
Average Volume
6,473 shs
Market Capitalization
$19.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ZIVO stock logo

About ZIVO Bioscience Stock (NASDAQ:ZIVO)

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

ZIVO Stock Price History

ZIVO Stock News Headlines

Harmony Biosciences Holdings
A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
Regencell Bioscience Holdings Ltd RGC
ZIVO Bioscience Announces Uplisting to OTCQB Market
Ideaya Biosciences
Dare Bioscience Inc DARE
A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
Zivo Bioscience Inc ZIVO
SK Bioscience Co Ltd (302440)
Maxim Group Keeps Their Buy Rating on Zivo Bioscience (ZIVO)
See More Headlines
Receive ZIVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/15/2024
Today
4/17/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ZIVO
Previous Symbol
OTCMKTS:HEPI
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Net Income
$-7,780,000.00
Pretax Margin
-28,126.58%

Debt

Sales & Book Value

Annual Sales
$30,000.00
Book Value
($0.81) per share

Miscellaneous

Free Float
2,406,000
Market Cap
$19.32 million
Optionable
Not Optionable
Beta
0.20
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. John B. Payne (Age 76)
    President, CEO & Chairman of the Board
    Comp: $572.75k
  • Mr. Keith R. Marchiando (Age 62)
    CFO, Treasurer & Secretary
    Comp: $362.5k
  • Dr. Harlan L. Miller III
    Vice President of Technology & Global Supply

ZIVO Stock Analysis - Frequently Asked Questions

How have ZIVO shares performed in 2024?

ZIVO Bioscience's stock was trading at $1.20 on January 1st, 2024. Since then, ZIVO stock has increased by 475.0% and is now trading at $6.90.
View the best growth stocks for 2024 here
.

When is ZIVO Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our ZIVO earnings forecast
.

How were ZIVO Bioscience's earnings last quarter?

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) posted its earnings results on Friday, March, 15th. The biotechnology company reported ($0.96) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $0.01 million for the quarter.

When did ZIVO Bioscience's stock split?

Shares of ZIVO Bioscience reverse split on Friday, October 27th 2023. The 1-6 reverse split was announced on Friday, October 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

How do I buy shares of ZIVO Bioscience?

Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ZIVO) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners